A 6 year-old child is comforted by her mother as she receives her first dose of the Pfizer-BioNTech COVID-19 vaccine by a medical assistant at the Child Health Associates office in Novi, Michigan on Nov 3, 2021. (JEFF KOWALSKY / AFP)
WASHINGTON / COPENHAGEN – Americans will have to pay for COVID-19 vaccines and treatments as soon as in January 2023, as US Congress has nearly run out of funds, The Washington Post has reported.
Earlier this month, the Department of Health and Human Services announced that commercial sales of COVID-19 vaccines, previously distributed by the US government and offered at no cost, could begin in early 2023, leaving Americans to obtain vaccines through insurers or pay by themselves, the report said.
Once federal purchases end, the roughly 8 percent of the US population that has no health insurance will be worst hit, it said.
Even those with health insurance will have to fund some of the cost out of pocket, which is a problem as cost of living is soaring in the United States, said the report, adding it is very likely that fewer eligible people will be driven to take their fourth shot.
This July 3, 2020 photo, shows a sign of the World Health Organization (WHO) at their headquarters in Geneva, amidst the COVID-19 outbreak, caused by the novel coronavirus. (Fabrice COFFRINI / AFP)
At least 17 million people in the World Health Organization European Region experienced the post-COVID-19 condition, or long COVID, in the first two years of the pandemic, said a statement from the United Nations health agency on Tuesday.
With millions of people likely to be affected by the aftereffects of contracting COVID during the pandemic "for years to come," WHO urged countries in the region to "take post COVID-19 condition seriously by urgently investing in research, recovery, and rehabilitation"
"Governments and health partners must collaborate to find solutions based on research and evidence," said Hans Kluge, WHO regional director for Europe, in the statement.
ALSO READ: Keeping long COVID at bay
With millions of people likely to be affected by the aftereffects of contracting COVID during the pandemic "for years to come," WHO urged countries in the region to "take post COVID-19 condition seriously by urgently investing in research, recovery, and rehabilitation."
The findings, which cover the years 2020 and 2021, come from a recent international "new modeling" study done for WHO Europe by the Institute for Health Metrics and Evaluation at the University of Washington's School of Medicine in the United States.
It shows a "staggering 307-percent increase in new long COVID cases identified between 2020 and 2021, driven by the rapid increase in confirmed COVID-19 cases from late 2020 and throughout 2021."
ALSO READ: EU backs BioNTech booster shot for COVID subvariants
According to the press release, the modeling also indicates that females are twice as likely as males to have long COVID.
Furthermore, among severe COVID-19 cases requiring hospital admissions, one in three females and one in five males are likely to develop long COVID.
The WHO defines the long COVID as "a constellation of long-term symptoms that some people experience after having COVID-19, such as fatigue, breathlessness, and cognitive dysfunction (for example, confusion, forgetfulness, or a lack of mental focus and clarity)."
ALSO READ: US orders 100m COVID tests, White House says more needed
"For these goals to be achieved, we need all countries in the Region to recognize that long COVID is a serious problem, with serious consequences and requires a serious response to stop the lives of those affected from getting any worse," said Kluge.